Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor.

Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor. J Clin Oncol. 2023 02 10; 41(5):1129-1131.

View in: PubMed

subject areas

Carcinoma, Non-Small-Cell Lung
ErbB Receptors
Humans
Lung Neoplasms
Mutation
Protein Kinase Inhibitors

authors with profiles

Ravi Salgia